Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,951 public trials 2,018 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Active, Not Recruiting

Ibrutinib Monotherapy Versus Fixed-duration Venetoclax Plus Obinutuzumab Versus Fixed-duration Ibrutinib Plus Venetoclax in Patients With Previously Untreated Chronic Lymphocytic Leukaemia (CLL)

NCT04608318

Conditions
Chronic Lymphoid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • LKH-Universtitätsklinikum Graz Graz, Austria
  • Landeskrankenhaus - Universitätskliniken Innsbruck Innsbruck, Austria
  • Medizinische Universität Wien Vienna, Austria
  • Hanusch Krankenhaus Vienna, Austria
View all 181 locations
View Trial Details
Active, Not Recruiting

Study of Selinexor and Venetoclax in Combination With Chemotherapy in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

NCT04898894

Conditions
Acute Leukemia of Ambiguous Lineage in Relapse, Acute Myeloid Leukemia, in Relapse, Hematologic Diseases, +14 more
Locations
  • Rady Children's Hospital-San Diego San Diego, California, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • Childrens Hospital of Philadelphia Philadelphia, Pennsylvania, United States
View Trial Details
Active, Not Recruiting

Study to Evaluate Loncastuximab Tesirine With Rituximab Versus Immunochemotherapy in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

NCT04384484

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations
  • University of California San Diego Moores Cancer Center La Jolla, California, United States
  • Redlands Community Hospital Redlands, California, United States
  • The Oncology Institute of Hope and Innovation Whittier, California, United States
  • Baptist MD Anderson Cancer Center Jacksonville, Florida, United States
View all 144 locations
View Trial Details
Active, Not Recruiting

PRospective Multiple Myeloma Impact Study

NCT02911571

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Lombardi Comprehensive Cancer Center Washington D.C., District of Columbia, United States
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • New York Presbyterian Brooklyn Methodist Hospital Brooklyn, New York, United States
View Trial Details

Related conditions